23rd Jul 2009 18:19
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of a change in the interests of Mr Jean Stéphenne, a Person Discharging Managerial Responsibility, in the Ordinary Shares of the Company as a result of the following acquisition of shares:-
On 22 July 2009, Mr Jean Stéphenne received the following award:-
Award under Ordinary Shares
GlaxoSmithKline R&D Employee Inventor 2,500
Award Programme ("the Programme")
The Programme was established by the Company in December 2007 to reward those GlaxoSmithKline employee inventors who are named on the Company's product patents upon the first product launch of the relevant patent category in a major market.
Mr Stéphenne, President and General Manager, GlaxoSmithKline Biologicals, is one of the inventors of Flu Pre-Pandemic (D-PAN) Vb61316.
The Ordinary shares subject to the award will be transferred to Mr Stéphenne as soon as practicable. In accordance with the rules of the Programme, there will be no restrictions attached to the shares. The price of an Ordinary Share on the date of award was £11.53.
The Company and Mr Stéphenne were advised of this transaction on 23 July 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
23 July 2009
Related Shares:
Glaxosmithkline